Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

All were waiting patiently as emergency crews retrieved the bodies of victims from part of an apartment block reduced to rubble in the assault. Each time, he rushed over to crews carrying victims ...

About Dementia with Lewy Bodies (DLB) DLB is the third most common ... in the hippocampus and associated Alzheimer’s Disease co-pathology – were excluded from the trial. The primary endpoint ...

The data set from the double-blind phase of the RewinD-LB trial presented today at ILBDC is now accessible in the Investor section of the CervoMed website https://www.cervomed.com/.

The initial topline results for the Phase 2b study of neflamapimod in dementia with Lewy bodies (DLB) were previously disclosed on December 10, 2024 and are available here. CervoMed Inc. is a clinical ...

Sue's Story: A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente and other health systems; in nursing programs offered by ...

Lewy Body Dementia: What Is It Really ... This spotlight on such a little-known pathology has undoubtedly helped many people to better understand what it involved, both medically and personally.

Jan. 28, 2025 /PRNewswire/ -- Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's Story: A Journey with Lewy Body Dementia ...

In mice, α-synuclein pathology spreads from the kidneys to the brain ... kidneys of 17 of 20 people with chronic kidney disease (CKD). Seven of them also had Lewy body- and Lewy neurite-like ...